I wrote to Merck & LLY, I told them that I am an investor in DNDN and expressed serious interest in selling them my shares in DNDN BUYOUT.
They will be getting back to me next week.
I specifically requested from Lilly an explanation as to the raising of $ 2.4 billion following their meeting with DNDN in January 2009.
I will keep you posted once I receive a response.
Don't you find it comical that DNDN is trying to keep a low profile, yet all of the body language clearly indicates a robust result from IMPACT clinical trial with pending buyout, all to occur in April 2009.